Assessment of efficacy and tolerability of olanzapine, risperidone, amisulpride and quetiapine at 4weeks in newly diagnosed patients of schizophrenia at M.Y. Hospital, Indore


Article PDF :

Veiw Full Text PDF

Article type :

Original Article

Author :

Gopal Gudsurkar, Pali Rastogi, Pooja Solanki, Shubham Atal

Volume :

4

Issue :

3

Abstract :

Objectives: Schizophrenia is a psychotic disorder characterized by hallucinations and delusions. Second generation antipsychotics are frequently used to treat the schizophrenia. As there are no clear-cut Indian guidelines for starting a particular drug for newly diagnosed cases of schizophrenia we decided to find out efficacy and tolerability of olanzapine, risperidone, quetiapine and amisulpride at 4 weeks after the initiation of treatment. Materials and Method: Newly diagnosed cases of schizophrenia of either sex between age group 18 to 65 were recruited;30 cases in each group[N-120, n-30]. Patients were prescribed either of the study drugs in oral tablet form. Efficacy was assessed by comparing baseline [day 0] and week 4scores of PANSS, CGI and GAF score and tolerability was assessed by UKU PERT scale at 4 week. Results: Olanzapine and risperidone statistically significantly reduced total PANSS score than amisulpride and quetiapine (p

Keyword :

Schizophrenia, PANSS, CGI, GAF